NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 1 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 10,000 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | -50.0% | 10,000 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2017 | $4,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2017 | $5,000 | -16.7% | 10,000 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | 0.0% | 10,000 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $6,000 | -33.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $9,000 | +80.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $5,000 | -44.4% | 10,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $9,000 | -60.9% | 10,000 | 0.0% | 0.00% | -75.0% |
Q3 2015 | $23,000 | +43.8% | 10,000 | 0.0% | 0.00% | +100.0% |
Q2 2015 | $16,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $16,000 | -15.8% | 10,000 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $19,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sowell Financial Services LLC | 506,634 | $190,000 | 0.05% |
Harel Insurance Investments & Financial Services Ltd. | 780,000 | $328,000 | 0.02% |
LifePlan Financial Group, Inc | 28,810 | $12,000 | 0.01% |
AURORA FINANCIAL ADVISORS, LLC | 32,500 | $11,000 | 0.01% |
WEDBUSH SECURITIES INC | 169,000 | $61,000 | 0.01% |
Greenwich Wealth Management LLC | 60,066 | $22,000 | 0.00% |
Jacobi Capital Management LLC | 20,130 | $8,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $233,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 436,272 | $156,000 | 0.00% |
McCollum Christoferson Group LLC | 17,155 | $6,000 | 0.00% |